Nanjing, China

Guohuang Fan

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Celebrating the Innovations of Guohuang Fan

Introduction: Guohuang Fan, an accomplished inventor based in Nanjing, China, has made significant strides in the field of biotechnology. With a focus on macrophage migration inhibitory factor (MIF) inhibitors, his research opens new avenues for treating diseases mediated by MIF. As a part of Nanjing Immunophage Biotech Co., Ltd., he embodies the spirit of innovation that drives progress in medical research.

Latest Patents: Guohuang Fan holds a patent for "Compounds and their uses as MIF inhibitors." This invention provides compounds of Formula I, which can effectively inhibit the activity of macrophage migration inhibitory factor. The patent details methods for producing these compounds, pharmaceutical compositions incorporating them, and strategies for utilizing these compounds in treating diseases linked to MIF.

Career Highlights: Throughout his career, Guohuang Fan has dedicated his efforts to pioneering research in the field of immunotherapy. His work contributes to developing new therapeutic options for patients with diseases that involve MIF, showcasing his ability to merge scientific knowledge with practical applications in medicine.

Collaborations: At Nanjing Immunophage Biotech Co., Ltd., Guohuang collaborates with talented colleagues, including Kin Chiu Fong and Hongyu Yang. These collaborations foster an innovative environment that encourages the exchange of ideas and enhances the overall research capabilities of the company.

Conclusion: Guohuang Fan stands out as a notable inventor in the realm of biotechnology, with his innovative approaches to MIF inhibitors making a substantial impact on medical research. His patent represents a significant advancement in understanding and potentially treating diseases associated with MIF, and his contributions continue to inspire others in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…